Adagene Company
Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies against novel epitopes. It has its proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody.
.jpeg)
.jpeg)
.png)
Industry:
End-to-end Drug Development
Headquarters:
Suzhou, Jiangsu, China
Founded Date:
2011-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
11
Total Funding:
155000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-02-11
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership